Prescription medicine

Dextrose, magnesium acetate, potassium acetate and sodium chloride

Dextrose, magnesium acetate, potassium acetate and sodium chloride is a prescription medicine with an FDA approval on record since 1975. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the dextrose, magnesium acetate, potassium acetate and sodium chloride FDA label on DailyMed (effective October 24, 2025, ICU Medical Inc.); the NDA 17610 record on Drugs@FDA; every dextrose, magnesium acetate, potassium acetate and sodium chloride label on DailyMed.

Highlights of the record

FDA label of October 24, 2025; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
Normosol-M and 5% Dextrose Injection (Multiple Electrolytes and 5% Dextrose Injection Type 1, USP) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose.

Forms and strengths

5 g/100ml / 234 mg/100ml / 128 mg/100ml / 21 mg/100ml

Injection (solution).

On the market

Earliest approval on file: August 13, 1975 Normosol-M And Dextrose 5% In Plastic Container, Otsuka Icu Medcl; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals: No generic approved
Labelers listed (NDC): 1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): No current entry
Recalls by its makers (FDA): No recall recorded

What is dextrose, magnesium acetate, potassium acetate and sodium chloride used for?

From the label: indications and usage
Normosol-M and 5% Dextrose Injection (Multiple Electrolytes and 5% Dextrose Injection Type 1, USP) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose. Magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy.

FDA pharmacologic class: Calculi Dissolution Agent, Osmotic Laxative and Potassium Salt.

Source: FDA drug label (NORMOSOL-M AND DEXTROSE), NDA017610 (Otsuka Icu Medcl), as published by ICU Medical Inc., effective October 24, 2025 (SPL set aba60c84-94d9-46d0-bdbb-25e0c4e8cc41), via openFDA; the full label on DailyMed

Is there a generic for dextrose, magnesium acetate, potassium acetate and sodium chloride?

No generic dextrose, magnesium acetate, potassium acetate and sodium chloride is approved (Drugs@FDA, October 8, 2026).

1975 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What next?

Other calculi dissolution agents: the pharmacologic class, with prices and generics
Check an interaction: what two or more labels say about each other